SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
Abstract Sodium-glucose co-transporter 2 inhibitors (SGLT2is), primarily used for managing type 2 diabetes mellitus, have recently gained attention for their potential cardiovascular benefits. This review explores the emerging evidence surrounding the association between SGLT2is and arrhythmias. Ini...
Main Authors: | Aritra Paul, Chadi Tabaja, Oussama Wazni |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | International Journal of Arrhythmia |
Online Access: | https://doi.org/10.1186/s42444-024-00109-6 |
Similar Items
-
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
by: Lucia Scisciola, et al.
Published: (2023-02-01) -
SGLT2 Inhibitors for Cardioprotection
by: Sulthan Al Rashid, et al.
Published: (2023-07-01) -
SGLT2 inhibitors and the cardiac Na+/H+ exchanger-1: the plot thickens
by: Chung, YJ, et al.
Published: (2021) -
Neuroprotective Effect of SGLT2 Inhibitors
by: Agnieszka Pawlos, et al.
Published: (2021-11-01) -
SGLT2 Inhibitors and Their Antiarrhythmic Properties
by: Ewald Kolesnik, et al.
Published: (2022-01-01)